) a"good buy," noting the momentum surrounding the company’s $2 trillion market capitalization. He explains how Amazon Web Services is benefiting from AI demand and points to Amazon’s cost-cutting and efficiency measures as another tailwind.), citing disappointing third quarter earnings, consumer weakness concerns, and the lack of an AI story against the challenges of the traditional retail model.Well, thanks for being here, thanks to the So let's get to your buy stock.
So that was one area of weakness that Amazon had in the last sort of couple of years, where the growth in that AWS business slowed down. But clearly, with the interest rate environment that repriced all business models like that, there had to be a focus on costs. And I think the market clearly loves that part of the Amazon story, hence part of the $2 trillion market cap.
The stock is already down some 50% or so over the past year, so kind of a mirror image of what we've seen with Amazon.That's right, Q three numbers were horrible, and I think again, it's a It's a It's a useful case to position it against a stock like Amazon to really think about the challenges that a lot of these traditional retailers are facing, and this is a combination of all sorts of factors.
The other challenge in pharmacy, of course, is the drug market and the fact that they can't fully control what they charge customers for prescription drugs.So kind of a few pressures there, gotcha, macro pressures as well.